chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lethargy, Myalgia, Pyrexia
Clinical narrative: lethargy; Fever; Chills; headache; muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargy), PYREXIA (Fever), CHILLS (Chills), HEADACHE (headache) and MYALGIA (muscle ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. CC1BZIA) for COVID-19 vaccination.     The patient's past medical history included Ovarian cancer (20-years ago) and Clot blood. Concurrent medical conditions included Diabetes and Glaucoma. Concomitant products included METFORMIN, PRASUGREL HYDROCHLORIDE (EFFIENT), GLIPIZIDE, FENOFIBRATE, LOSARTAN, TRAZODONE, ATORVASTATIN, LINAGLIPTIN (TRADJENTA), EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA), MECLIZINE [MECLOZINE], ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], FOLIC ACID, ZINC, CALCIUM and MAGNESIUM for an unknown indication.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargy), PYREXIA (Fever), CHILLS (Chills), HEADACHE (headache) and MYALGIA (muscle ache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, LETHARGY (lethargy), PYREXIA (Fever), CHILLS (Chills), HEADACHE (headache) and MYALGIA (muscle ache) outcome was unknown.            The patient was taking eyedrops for glaucoma and sulfate for unknown indication.  The patient mentioned that she took Tylenol and symptoms lasted 2 days.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Erythema, Headache
Clinical narrative: My arm started itching severely/my arm is still itching; My arm was blush red; No appetite; high temperature of 101.8F; chills; body aches; severe headache/ Mild headache; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA, DECREASED APPETITE, PRURITUS, PYREXIA, and CHILLS in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced DECREASED APPETITE, PYREXIA, CHILLS, MYALGIA, HEADACHE, and NAUSEA. On 30-Nov-2021, the patient experienced ERYTHEMA and PRURITUS. The patient was treated with PARACETAMOL at a dose of 500 milligram, 3 in 24hrs. At the time of the report, ERYTHEMA, DECREASED APPETITE, PRURITUS, PYREXIA, CHILLS, MYALGIA, and NAUSEA outcome was unknown and HEADACHE was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 29-Nov-2021, Body temperature: 101.8F (High).         The concomitant medications were not reported.   This case was linked to MOD-2021-403057, MOD-2021-403058 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pruritus, Pyrexia
Clinical narrative: My arm started itching severely/my arm is still itching; My arm was blush red; No appetite; high temperature of 101.8F; chills; body aches; severe headache/ Mild headache; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA, DECREASED APPETITE, PRURITUS, PYREXIA, and CHILLS in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced DECREASED APPETITE, PYREXIA, CHILLS, MYALGIA, HEADACHE, and NAUSEA. On 30-Nov-2021, the patient experienced ERYTHEMA and PRURITUS. The patient was treated with PARACETAMOL at a dose of 500 milligram, 3 in 24hrs. At the time of the report, ERYTHEMA, DECREASED APPETITE, PRURITUS, PYREXIA, CHILLS, MYALGIA, and NAUSEA outcome was unknown and HEADACHE was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 29-Nov-2021, Body temperature: 101.8F (High).         The concomitant medications were not reported.   This case was linked to MOD-2021-403057, MOD-2021-403058 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Malaise, Nasopharyngitis, Pain in extremity
Clinical narrative: Arm was really sore; Felt a little off, like she had a small cold for a few days.; Small cold for a few days; It stayed red for weeks; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was really sore), MALAISE (Felt a little off, like she had a small cold for a few days.), NASOPHARYNGITIS (Small cold for a few days) and ERYTHEMA (It stayed red for weeks) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Dressler's syndrome (Pericarditis, 8-9 yrs ago), COVID-19 (2 times, cannot remember when  tested positive for 1st time. Several months later, about 7 or 8 months ago, patient's Doctor thought she had the Delta strain. He treated her with antibiotics.), Hip replacement (Patient had 2 hip replacements. Left hip done 7 months ago), Surgery (About 8 or 9 yrs ago, Mini-Maze heart surgery.) and Thoracotomy (Approximately 7 yrs ago, took blood out of patient's lungs.). Concurrent medical conditions included Heart failure, Tachycardia, Bradycardia, Atrial fibrillation, Atrial flutter and COPD. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was really sore), MALAISE (Felt a little off, like she had a small cold for a few days.), NASOPHARYNGITIS (Small cold for a few days) and ERYTHEMA (It stayed red for weeks). The patient was treated with ALBUTEROL [SALBUTAMOL] for Adverse event, at a dose of UNK, qd and AMOXICILLIN for Adverse event, at a dose of 875 mg twice a day. At the time of the report, PAIN IN EXTREMITY (Arm was really sore) and MALAISE (Felt a little off, like she had a small cold for a few days.) outcome was unknown and NASOPHARYNGITIS (Small cold for a few days) and ERYTHEMA (It stayed red for weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-404300, MOD-2021-404419 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysstasia, Gait inability, Hypersensitivity, Joint swelling
Clinical narrative: pain in hands; neck pain; swelling in my left ankle; stiffness; unable to walk; inability to stand; pain in hip; type 4 type reaction; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness) and GAIT INABILITY (unable to walk) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RIMEGEPANT SULFATE (NURTEC ODT) for Migraine.    Concurrent medical conditions included Migraine.   On 11-Mar-2021, the patient started RIMEGEPANT SULFATE (NURTEC ODT) (Oral) 1 dosage form. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction). The patient was treated with PREDNISONE for Joint pain, at a dose of 1 dosage form and METHOTREXATE for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No any concomitant medications were reported.  Patient's Lab test- All test for Rheumatoid arthritis- Negative.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Pain in extremity
Clinical narrative: pain in hands; neck pain; swelling in my left ankle; stiffness; unable to walk; inability to stand; pain in hip; type 4 type reaction; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness) and GAIT INABILITY (unable to walk) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RIMEGEPANT SULFATE (NURTEC ODT) for Migraine.    Concurrent medical conditions included Migraine.   On 11-Mar-2021, the patient started RIMEGEPANT SULFATE (NURTEC ODT) (Oral) 1 dosage form. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction). The patient was treated with PREDNISONE for Joint pain, at a dose of 1 dosage form and METHOTREXATE for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No any concomitant medications were reported.  Patient's Lab test- All test for Rheumatoid arthritis- Negative.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash
Clinical narrative: I have itchy and swollen hands and feet; I have itchy and swollen hands and feet; I am experiencing a full body rash on face neck trunk legs arm and feet; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (I have itchy and swollen hands and feet), PERIPHERAL SWELLING (I have itchy and swollen hands and feet) and RASH (I am experiencing a full body rash on face neck trunk legs arm and feet) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018F1A, 010M20A and 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE (ALYACEN 1/35) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (I have itchy and swollen hands and feet), PERIPHERAL SWELLING (I have itchy and swollen hands and feet) and RASH (I am experiencing a full body rash on face neck trunk legs arm and feet). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (I have itchy and swollen hands and feet) and PERIPHERAL SWELLING (I have itchy and swollen hands and feet) outcome was unknown and RASH (I am experiencing a full body rash on face neck trunk legs arm and feet) had not resolved.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: I feel off; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2021.    On 04-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL. At the time of the report, FEELING ABNORMAL outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: had a lot of lymph node swelling, and they were painful; had a lot of lymph node swelling, and they were painful; This spontaneous case was reported by a health care professional and describes the occurrence of LYMPHADENOPATHY and LYMPH NODE PAIN in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY and LYMPH NODE PAIN. At the time of the report, LYMPHADENOPATHY had not resolved and LYMPH NODE PAIN outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-405000 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Had a reaction after Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a reaction after Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had a reaction after Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Had a reaction after Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported. Treatment information was not reported.  Reporter stated that 2 of the friends had a reaction after Moderna vaccine.   Reporter did not allow further contact
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Feeling hot, Headache, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: Bad reaction to the booster dose; Felt warm; Temperature of 99.6 degrees/ slight fever; Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm), PYREXIA (Temperature of 99.6 degrees/ slight fever), HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine. Past adverse reactions to the above products included No adverse event with Pfizer vaccine. Concomitant products included ESCITALOPRAM and MELOXICAM for an unknown indication.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.). 29-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm) and PYREXIA (Temperature of 99.6 degrees/ slight fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Headache, at an unspecified dose and frequency. On 29-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm) and PYREXIA (Temperature of 99.6 degrees/ slight fever) outcome was unknown and HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.6 (High) 99.6 Fahrenheit.         Patient stated that he thinks he received the full dose for his booster dose.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Bad reaction to the booster dose; Felt warm; Temperature of 99.6 degrees/ slight fever; Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm), PYREXIA (Temperature of 99.6 degrees/ slight fever), HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine. Past adverse reactions to the above products included No adverse event with Pfizer vaccine. Concomitant products included ESCITALOPRAM and MELOXICAM for an unknown indication.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.). 29-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm) and PYREXIA (Temperature of 99.6 degrees/ slight fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Headache, at an unspecified dose and frequency. On 29-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, VACCINATION COMPLICATION (Bad reaction to the booster dose), FEELING HOT (Felt warm) and PYREXIA (Temperature of 99.6 degrees/ slight fever) outcome was unknown and HEADACHE (Experienced bad headaches 2 hours after the vaccine/ the headache lasted for two days.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.6 (High) 99.6 Fahrenheit.         Patient stated that he thinks he received the full dose for his booster dose.
Sex: M
Vaccine: COVID19
Symptoms: Paranoia, Product dose omission issue
Clinical narrative: Paranoid; not yet received a second dose at this time; This spontaneous case was reported by a consumer and describes the occurrence of PARANOIA (Paranoid) and PRODUCT DOSE OMISSION ISSUE (not yet received a second dose at this time) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (not yet received a second dose at this time). On an unknown date, the patient experienced PARANOIA (Paranoid). In March 2021, PRODUCT DOSE OMISSION ISSUE (not yet received a second dose at this time) had resolved. At the time of the report, PARANOIA (Paranoid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitants medications were provided.   Treatment medications were reported.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm after initial series; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after initial series) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Tracheostomy. Concurrent medical conditions included Diabetes, Cholesterol, Blood pressure high and Heart disorder.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (sore arm after initial series). In April 2021, PAIN IN EXTREMITY (sore arm after initial series) had resolved.            Concomitant medications included are medication for sugar, medication for the heart, medication for cholesterol, medication for high blood pressure. Tracheotomy was done on neck and problem with lung, from before.  No treatment drug details was reported.   This case was linked to MOD-2021-405019, MOD-2021-405029 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Urticaria, Vaccination complication
Clinical narrative: hives covering entire body; really really intense reaction; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction). At the time of the report, URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-406162 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Patient experienced a sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient experienced a sore left arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jul-2021, the patient experienced VACCINATION SITE PAIN (Patient experienced a sore left arm). At the time of the report, VACCINATION SITE PAIN (Patient experienced a sore left arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-405045 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: inappropriate schedule of vaccine administered; coughing until throwing up; fever; chills; floating headache; coughing until throwing up; This spontaneous case was reported by a consumer and describes the occurrence of COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19, tested positive for COVID in December 2020. Previously administered products included for Product used for unknown indication Pfizer (Dose 1 Batch number EN5318) on 03-Apr-2021 and Pfizer (Dose 2 Batch number EW0161) on 24-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer. Concurrent medical conditions included Blood pressure high, Hypercholesterolemia, Smoker and Smokers Cough.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING. On 29-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. The patient was treated with IBUPROFEN at a dose of the first day and ACETAMINOPHEN at a dose of the second night. On 29-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION had resolved. At the time of the report, COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) In December 2020, SARS-CoV-2 test tested positive for COVID.         Patient stated that  she did not experienced these events with Pfizer doses.  Concomitant medications include for blood pressure and cholesterol.  Patient had bad reactions to the vaccine. It was reported that on 01-Dec-2021, patient felt better.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: inappropriate schedule of vaccine administered; coughing until throwing up; fever; chills; floating headache; coughing until throwing up; This spontaneous case was reported by a consumer and describes the occurrence of COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19, tested positive for COVID in December 2020. Previously administered products included for Product used for unknown indication Pfizer (Dose 1 Batch number EN5318) on 03-Apr-2021 and Pfizer (Dose 2 Batch number EW0161) on 24-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer. Concurrent medical conditions included Blood pressure high, Hypercholesterolemia, Smoker and Smokers Cough.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING. On 29-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. The patient was treated with IBUPROFEN at a dose of the first day and ACETAMINOPHEN at a dose of the second night. On 29-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION had resolved. At the time of the report, COUGH, PYREXIA, CHILLS, HEADACHE, and VOMITING was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) In December 2020, SARS-CoV-2 test tested positive for COVID.         Patient stated that  she did not experienced these events with Pfizer doses.  Concomitant medications include for blood pressure and cholesterol.  Patient had bad reactions to the vaccine. It was reported that on 01-Dec-2021, patient felt better.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Inappropriate schedule of product administration
Clinical narrative: Headaches literally right before she is due to get her next injection series; Inappropriate schedule of vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headaches literally right before she is due to get her next injection series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 immunisation.    Concurrent medical conditions included Chronic migraine. Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) for Chronic migraine.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced HEADACHE (Headaches literally right before she is due to get her next injection series). On 09-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, HEADACHE (Headaches literally right before she is due to get her next injection series) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was on Botox for chronic migrations for 3 years.. No treatment medications were reported.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: He had terrible itch in different areas of the body about 1 week or more after the booster shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (He had terrible itch in different areas of the body about 1 week or more after the booster shot) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, 011A21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (He had terrible itch in different areas of the body about 1 week or more after the booster shot). At the time of the report, PRURITUS (He had terrible itch in different areas of the body about 1 week or more after the booster shot) outcome was unknown.            Concomitant medication was not reported. Treatment Over the counter lotion.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity, Peripheral swelling, Vaccination complication
Clinical narrative: averse reaction; Arm swelled up; I am allergic to something in it; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (averse reaction), PERIPHERAL SWELLING (Arm swelled up) and HYPERSENSITIVITY (I am allergic to something in it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (averse reaction), PERIPHERAL SWELLING (Arm swelled up) and HYPERSENSITIVITY (I am allergic to something in it). At the time of the report, VACCINATION COMPLICATION (averse reaction), PERIPHERAL SWELLING (Arm swelled up) and HYPERSENSITIVITY (I am allergic to something in it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   Reporter did not allow further contact
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Generalised oedema, Peripheral swelling, Swelling
Clinical narrative: the swelling in generalized and it looks like he worked out more on his left side & now looks buff; left shoulder swelled up again and the swelling went into his armpit & chest area; and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again; This spontaneous case was reported by a consumer and describes the occurrence of GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff), PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0033F21A, 012M20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff), PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again). At the time of the report, GENERALISED OEDEMA (the swelling in generalized and it looks like he worked out more on his left side & now looks buff) had not resolved and PERIPHERAL SWELLING (left shoulder swelled up again and the swelling went into his armpit & chest area) and SWELLING (and the swelling went into his armpit & chest area/After the booster dose his left shoulder swelled up again) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.   This case was linked to MOD-2021-405151 (Patient Link).
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pyrexia, Vaccination site pain
Clinical narrative: pain at injection site; chills; low fever; axillary LN swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), CHILLS (chills), PYREXIA (low fever) and LYMPHADENOPATHY (axillary LN swelling) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at injection site), CHILLS (chills), PYREXIA (low fever) and LYMPHADENOPATHY (axillary LN swelling). At the time of the report, VACCINATION SITE PAIN (pain at injection site), CHILLS (chills), PYREXIA (low fever) and LYMPHADENOPATHY (axillary LN swelling) had resolved. Not Provided          Pain at injection site started after 6 hours of vaccination and ended 4 days later, Chills and low fever started after 24 hours of vaccination and ended 36 hours later, Axillary LN swelling started after 24 hours of vaccination and ended 3 days later.  No concomitant product reported by reporter. No treatment medication reported by reporter.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants were provided. No treatment was provided.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 23-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 23-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Illness, Nausea, Pain in extremity
Clinical narrative: sick after the shot; sore arm; headache; nausea for a day or two; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick after the shot), PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and NAUSEA (nausea for a day or two) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick after the shot), PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and NAUSEA (nausea for a day or two). At the time of the report, ILLNESS (sick after the shot), PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) outcome was unknown and NAUSEA (nausea for a day or two) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was reported. It was reported that the reporter's co-workers that got either Moderna or Pfizer and experienced symptoms.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021 at 11:54 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 16-Sep-2021 at 11:54 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021 at 11:54 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given. Reportedly, patient vaccine status was 1/2 COVID received. Vaccines were not in the fridge for more than a day unless patients did not appear for their vaccine.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021 at 11:49 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 16-Sep-2021 at 11:49 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021 at 11:49 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medications were reported. no treatment medications were reported.   Reporter did not allow further contact
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 11:22 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021 at 12:49 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Aug-2021 at 12:49 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 26-Aug-2021 at 12:49 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A1A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2001, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter.